European Cytokine Network

, Volume 25, Issue 1, pp 24–29 | Cite as

Determination of IL-23 receptor gene polymorphism in Iranian patients with ankylosing spondylitis

  • Gholamreza Daryabor
  • Mahdi Mahmoudi
  • Ahmadreza Jamshidi
  • Keramat Nourijelyani
  • Aliakbar Amirzargar
  • Nooshin Ahmadzadeh
  • Elham Farhadi
  • Mohammad Hossein Nicknam
Research Article



The result of recent genome-wide association studies revealed that, in addition to HLA-B27, a few non-HLA genes are associated with susceptibility to ankylosing spondylitis (AS) in Caucasian populations. According to these studies, IL-23R is one of the genes that is associated with AS. In this study, we evaluated five important single nucleotide polymorphisms (SNPs) of the IL-23R gene which confers susceptibility to AS, and its effects on the severity of the disease in HLA-B27 positive and negative patients and several subtypes of HLA-B27.

Materials and methods

The study population consisted of 294 AS patients and 352 age-, sex-, and ethnicity-matched healthy controls. All patients were examined by rheumatologists, and met modified,NewYork criteria for the disease. Five SNPs (rs1004819, rs11209032, rs1495965, rs11465804, and rs1004819) of the IL-23R gene were genotyped using the Real-Time PCR TaqMan genotyping method.


We found that only rs1004819 has a significant association with AS, and that the remaining four SNP alleles are not associated with AS. Also, there was no association between these five polymorphisms and BASDAI, BASFI, and BASMI indices. Two haplotypes, ACGAT and ACGAG, were found to be associated with the heritability of AS. In addition, two significant, protective diplotypes (D8, \(\frac{{GCGAG}} {{GTGGG}}\); and D9, \(\frac{{ACGAG}} {{GCGAG}}\)) were discovered.


This study supported our previous findings regarding the differences between the genetic patterns of AS in Iranian patients compared with those in other parts of the world.

Key words

ankylosing spondylitis HLA-B27 IL23R SNP 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Melis L, Elewaut D. Immunopathogenesis of spondyloarthritis: which cells drive. Arthritis Res Ther 2009; 11: 233.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Sambrook PN, Geusens P. The epidemiology of osteoporosis and fractures in ankylosing spondylitis. Ther Adv Musculoskelet Dis 2012; 4: 287–92.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Shahlaee A, Mahmoudi M, Nicknam MH, Farhadi E, Fallahi S, Jamshidi AR. Gender differences in Iranian patients with ankylosing spondylitis. Clin Rheumatol 2013: 1–9.Google Scholar
  4. 4.
    Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Rheumatol Int 2003; 23: 61–6.Google Scholar
  5. 5.
    Braun J, Sieper J. Ankylosing spondylitis. The Lancet 2007; 369: 1379–90.CrossRefGoogle Scholar
  6. 6.
    Calin A. Ankylosing spondylitis. Medicine 2006; 34: 396–400.CrossRefGoogle Scholar
  7. 7.
    Brown M. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 2008; 47: 132–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev 2009; 233: 162–80.CrossRefGoogle Scholar
  9. 9.
    Reveille JD. Genetics of spondyloarthritis-beyond the MHC. Nat Rev Rheumatol 2012; 8: 296–304.PubMedCrossRefGoogle Scholar
  10. 10.
    Brown MA. Genetics and the pathogenesis of ankylosing spondylitis. Cur Opin Rheumatol 2009; 21: 318–23.CrossRefGoogle Scholar
  11. 11.
    O’Rielly DD, Rahman P. Curr Rheumatol Rep 2013; 15: 347.PubMedCrossRefGoogle Scholar
  12. 12.
    Robinson PC, Brown MA. The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheum Dis Clin North Am 2012; 38: 539–53.PubMedCrossRefGoogle Scholar
  13. 13.
    Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329–37.PubMedCrossRefGoogle Scholar
  14. 14.
    Evans DM, Spencer CC, Pointon JJ, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011; 43: 761–7.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Reveille JD, Sims AM, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010; 42: 123–7.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of TH17 cells. Nature 2008; 453: 1051–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Reich DE, Cargill M, Bolk S, et al. Linkage disequilibrium in the human genome. Nature 2001; 411: 199–204.PubMedCrossRefGoogle Scholar
  18. 18.
    Daimon M, Kido T, Baba M, et al. Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population. Biochem Biophys Res Com 2005; 329: 205–10.PubMedCrossRefGoogle Scholar
  19. 19.
    van der Heijde D, van der Linden S, Bellamy N, Calin A, Dougados M, Khan MA. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 1999; 26: 945–7.PubMedGoogle Scholar
  20. 20.
    Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286–91.PubMedGoogle Scholar
  21. 21.
    Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-5.Google Scholar
  22. 22.
    Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A. A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol 1995; 22: 1609.PubMedGoogle Scholar
  23. 23.
    Bidad K, Fallahi S, Mahmoudi M, et al. Evaluation of the Iranian versions of the bath ankylosing spondylitis disease activity index (BASDAI), the bath ankylosing spondylitis functional index (BASFI) and the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Rheumatol Int 2012; 32: 3613–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Roe B, Crabtree J, Khan A. Methods for DNA isolation. Part III. Protocols for recombinant DNA isolation, cloning, and sequencing [Internet edition]. Norman, OK: University of Oklahoma, 1995: 2488–98.Google Scholar
  25. 25.
    R Development Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.Google Scholar
  26. 26.
    Nicknam MH, Mahmoudi M, Amirzargar AA, et al. Determination ofHLA-B27subtypes in Iranian patients with ankylosing spondylitis. Iran J Allergy Asthma Immunol 2008; 7: 19–24.PubMedGoogle Scholar
  27. 27.
    Gonzalez S, Garcia-Fernandez S, Martinez-Borra J, et al. High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain. Hum Immunol 2002; 63: 673–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Kaijzel EL, Brinkman BM, van Krugten MV, et al. Polymorphism within the tumor necrosis factor alpha (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol 1999; 60: 140–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Nicknam MH, Mahmoudi M, Amirzargar AA, et al. Determination ofHLA-B27subtypes in Iranian patients with ankylosing spondylitis. Iran J Allergy Asthma Immunol 2008; 7: 19–24.PubMedGoogle Scholar
  30. 30.
    Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R 1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168: 5699.PubMedCrossRefGoogle Scholar
  31. 31.
    Veerdonk F, Gresnigt MS, Kullberg BJ, van der Meer JW, Joosten LA, Netea MG. Th17 responses and host defense against microorganisms: an overview. BMB Rep 2009; 42: 776–87.PubMedCrossRefGoogle Scholar
  32. 32.
    Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25: 221–42.PubMedCrossRefGoogle Scholar
  33. 33.
    Karaderi T, Harvey D, Farrar C, et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology 2009; 48: 386–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Pimentel-Santos, F., Ligeiro D, Matos M., et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. 2009.Google Scholar
  35. 35.
    Rueda B, Orozco G, Raya E, et al. The IL23R Arg381Gln nonsynonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008; 67: 1451–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Chen C, Zhang X, Li J, Wang Y. Associations of IL-23R polymorphisms with ankylosing spondylitis in East Asian population: a new case-control study and a meta-analysis. Int J Immunogenet 2012; 39: 126–30.PubMedCrossRefGoogle Scholar
  37. 37.
    Davidson SI, Wu X, Liu Y, et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009; 60: 3263–8.PubMedCrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2014

Authors and Affiliations

  • Gholamreza Daryabor
    • 1
  • Mahdi Mahmoudi
    • 2
  • Ahmadreza Jamshidi
    • 2
  • Keramat Nourijelyani
    • 3
  • Aliakbar Amirzargar
    • 1
  • Nooshin Ahmadzadeh
    • 2
  • Elham Farhadi
    • 4
  • Mohammad Hossein Nicknam
    • 1
  1. 1.Molecular Immunology Research CenterTehran University of Medical SciencesTehranIran
  2. 2.Rheumatology Research CenterShariati Hospital, Tehran University of Medical SciencesTehranIran
  3. 3.Department of Epidemiology and Biostatistics, School of Public HealthTehran University of Medical SciencesTehranIran
  4. 4.Hematology Department, School of Allied Medical SciencesIran University of Medical SciencesTehranIran

Personalised recommendations